Literature DB >> 12755487

Identifying and validating causal genetic alterations in human breast cancer.

Stephen P Ethier1.   

Abstract

An important mechanism for the activation of proto-oncogenes in human breast and other cancers is gene amplification, which results in gene overexpression at both the message and the protein levels. Recent studies have demonstrated that oncogenes rarely if ever become amplified in isolation, but rather are present on large amplicons that contain multiple genes. More detailed analysis of these amplicons has revealed the presence of many candidate breast cancer oncogenes. The broad goal of this issue of Breast Cancer Research and Treatment is to review the current state of our understanding of the causal role of defined genetic alterations that occur in human breast cancers, and to discuss the case for the mechanistic significance of several candidate oncogenes. As will be seen, these studies have revealed a remarkable genetic complexity and heterogeneity in human breast cancer that must be dissected in order to improve our mechanistic understanding of disease progression, and to develop effective new drugs against relevant molecular targets.

Entities:  

Mesh:

Year:  2003        PMID: 12755487     DOI: 10.1023/a:1023078722316

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  5 in total

1.  Immutable functional attributes of histologic grade revealed by context-independent gene expression in primary breast cancer cells.

Authors:  Shanaz H Dairkee; Aejaz Sayeed; Gloria Luciani; Stacey Champion; Zhenhang Meng; Lakshmi R Jakkula; Heidi S Feiler; Joe W Gray; Dan H Moore
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

2.  Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression.

Authors:  Oleg V Grinchuk; Efthimios Motakis; Vladimir A Kuznetsov
Journal:  BMC Genomics       Date:  2010-02-10       Impact factor: 3.969

3.  Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer.

Authors:  Emma Yue Zhang; Massimo Cristofanilli; Fredika Robertson; James M Reuben; Zhaomei Mu; Ronald C Beavis; Hogune Im; Michael Snyder; Matan Hofree; Trey Ideker; Gilbert S Omenn; Susan Fanayan; Seul-Ki Jeong; Young-Ki Paik; Anna Fan Zhang; Shiaw-Lin Wu; William S Hancock
Journal:  J Proteome Res       Date:  2013-05-22       Impact factor: 4.466

4.  miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.

Authors:  Bisrat G Debeb; Lara Lacerda; Simone Anfossi; Parmeswaran Diagaradjane; Khoi Chu; Arvind Bambhroliya; Lei Huo; Caimiao Wei; Richard A Larson; Adam R Wolfe; Wei Xu; Daniel L Smith; Li Li; Cristina Ivan; Pamela K Allen; Wenhui Wu; George A Calin; Savitri Krishnamurthy; Xiang H Zhang; Thomas A Buchholz; Naoto T Ueno; James M Reuben; Wendy A Woodward
Journal:  J Natl Cancer Inst       Date:  2016-04-13       Impact factor: 13.506

5.  Alterations of GPI transamidase subunits in head and neck squamous carcinoma.

Authors:  Wei-Wen Jiang; Marianna Zahurak; Zeng-Tong Zhou; Hannah Lui Park; Zhong-Min Guo; Guo-Jun Wu; David Sidransky; Barry Trink; Joseph A Califano
Journal:  Mol Cancer       Date:  2007-11-21       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.